Article
Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma
12 Feb 2019
Abstract excerpt
Scleroderma (SSc) is a complex disease that involves activation of the immune system, vascular complications, and tissue fibrosis. The histone methyltransferase enhancer of zeste homolog 2 (EZH2) mediates trimethylation of lysine 27 of histone 3 (H3K27me3), which acts as a repressive epigenetic mark. Both EZH2 and H3K27me3 were elevated in SSc dermal fibroblasts and endothelial cells compared with healthy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
